Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Flaxseed
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Polpharma
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Through the acquisition, Polpharma enhanced its portfolio of OTC & dermatology products, including Linomag (linseed oil), which is indicated for treating skin conditions such as eczema & intertrigo.
Product Name : Linomag
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
January 10, 2024
Lead Product(s) : Flaxseed
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Polpharma
Deal Size : Undisclosed
Deal Type : Acquisition